April 24, 2019

Sirio group Ayanda launches probiotic softgel

Patent-pending technology is the first ever to enable a softgel capsule to contain both probiotic bacteria and Omega 3 oil. Ayanda – the ...

Read More
April 22, 2019

FSD Pharma Receives Cannabis Sales License from Canntab

FSD Pharma Inc., announced today that its wholly-owned subsidiary FV Pharma Inc. has received its Sale for Medical Purposes license to sell canna ...

Read More
April 22, 2019

Poseida Therapeutics uses genome engineering to develop cancer treatments

Poseida Therapeutics a company in which Dublin-listed life-sciences investment group Malin has a significant stake, has raise ...

Read More
April 20, 2019

Scientific breakthrough provides new hope for millions of people...

Researchers at Oregon Health & Science University have developed a compound that stimulates repair of the protective sheath that covers nerve ...

Read More
April 20, 2019

Israel’s Teva Pharmaceuticals gets FDA approval for 1st generic...

Israeli pharmaceutical company secures green light from US regulators for its version of Narcan AP — US regulators have approved the ...

Read More
April 17, 2019

Trial results show promise for chemo-free treatment

Promising results from a global study have shown that patients with chronic lymphocytic leukaemia (CLL) may be offered a chemotherapy-free treatm ...

Read More
April 17, 2019

The finalists announced for the Med-Tech Innovation award categories

The five new Med-Tech Innovation award categories will sit alongside the Medilink UK categories at this year’s awards and gala dinner, as a ...

Read More
April 15, 2019

Alnylam to file gene-silencing technology porphyria drug

Alnylam is to file its givosiran with regulators to treat a form of the blood disease porphyria, applying its gene silencing technology to the co ...

Read More
April 15, 2019

European Medicines Agency recommends temporarily restricting Lemtrada use in...

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has started a review of Sanofi’s multiple sclerosi ...

Read More